PMID: 22355912Feb 24, 2012Paper

New clinical criteria for the Alzheimer's disease spectrum

Minnesota Medicine
Ronald C Petersen

Abstract

New criteria for diagnosing Alzheimer's disease (AD) were recently published. These criteria cover the entire spectrum of AD including dementia due to AD, mild cognitive impairment due to AD, and preclinical AD. A major feature of the new criteria is that they distinguish between the clinical characteristics of the disorder and the pathological features. Earlier criteria were based on clinical features alone. The new criteria include the use of imaging and other biomarkers to aid in diagnosis. The criteria regarding clinical features are currently being used in practice; the criteria regarding biomarkers still need to be validated.

Related Concepts

Related Feeds

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Expert Review of Molecular Diagnostics
Malcolm Ward
American Journal of Optometry and Archives of American Academy of Optometry
P G SLOAN
Expert Review of Neurotherapeutics
Craig Gordon, Daniel J Martin
Nuclear Medicine Communications
Adil Al-Nahhas
© 2022 Meta ULC. All rights reserved